Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$40.39 - $56.73 $6,260 - $8,793
-155 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$51.77 - $66.18 $8,024 - $10,257
155 New
155 $8,000
Q1 2020

May 13, 2020

SELL
$33.63 - $69.4 $16,815 - $34,700
-500 Closed
0 $0
Q4 2019

Feb 10, 2020

SELL
$31.7 - $69.93 $117,290 - $258,741
-3,700 Reduced 88.1%
500 $31,000
Q3 2019

Nov 12, 2019

BUY
$19.95 - $38.85 $83,790 - $163,170
4,200 New
4,200 $142,000
Q4 2018

Feb 13, 2019

SELL
$19.08 - $36.14 $2,919 - $5,529
-153 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$33.57 - $42.1 $71,302 - $89,420
-2,124 Reduced 93.28%
153 $5,000
Q2 2018

Aug 13, 2018

BUY
$20.06 - $44.95 $45,676 - $102,351
2,277 New
2,277 $89,000

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.